Optical coherence tomography versus intravascular ultrasound to evaluate coronary artery disease and percutaneous coronary intervention

JACC: Cardiovascular Interventions

Volumn 6, Issue 3, 2013, Pages 228-236

  Bezerra, Hiram G ^a   Attizzani, Guilherme F ^a   Sirbu, Vasile ^b   Musumeci, Giuseppe ^b   Lortkipanidze, Nikoloz ^b   Fujino, Yusuke ^a   Wang, Wei ^a   Nakamura, Sunao ^c   Erglis, Andrej ^d,e   Guagliumi, Giulio ^b   Costa, Marco A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b OSPEDALI RIUNITI   (Italy)

^c NEW TOKYO HOSPITAL   (Japan)

^d PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

^e UNIVERSITY OF LATVIA   (Latvia)

Author keywords

Intravascular ultrasound; Optical coherence tomography; Percutaneous coronary intervention

Indexed keywords

AGED; ARTICLE; CATHETER; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EVALUATION; FEMALE; FOLLOW UP; FREQUENCY DOMAIN OPTICAL COHERENCE TOMOGRAPHY; HUMAN; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; TIME DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TISSUE INJURY; ANALYSIS OF VARIANCE; CELL PROLIFERATION; COMPARATIVE STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY BLOOD VESSEL; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; EQUIPMENT; HYPERPLASIA; MIDDLE AGED; NEOINTIMA; PATHOLOGY; PREDICTIVE VALUE; RESTENOSIS; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; STENT; TIME; TREATMENT OUTCOME;

AGED; ANALYSIS OF VARIANCE; CELL PROLIFERATION; CORONARY RESTENOSIS; CORONARY STENOSIS; CORONARY VESSELS; FEMALE; HUMANS; HYPERPLASIA; LINEAR MODELS; MALE; MIDDLE AGED; NEOINTIMA; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; STENTS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84880994810     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2012.09.017     Document Type: Article

References (27)

1. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-88.
2. Moussa I, Moses J, Di Mario C, et al. Does the specific intravascular ultrasound criterion used to optimize stent expansion have an impact on the probability of stent restenosis? Am J Cardiol 1999;83:1012-7.
3. Russo RJ, Silva PD, Teirstein PS, et al. A randomized controlled trial of angiography versus intravascular ultrasound-directed bare-metal coronary stent placement (the AVID trial). Circ Cardiovasc Interv 2009;2:113-23.
4. Doi H, Maehara A, Mintz GS, et al. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the Taxus IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent trials. J Am Coll Cardiol Intv 2009;2:1269 -75.
5. Jiménez-Quevedo P, Sabaté M, Angiolillo DJ, et al. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: threedimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) trial. J Am Coll Cardiol 2006;47:2172-9.
6. Nissen SE, Gurley JC, Grines CL, et al. Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation 1991;84:1087-99.
7. Hoffmann R, Haager P, Mintz GS, et al. The impact of high pressure vs low pressure stent implantation on intimal hyperplasia and follow-up lumen dimensions; results of a randomized trial. Eur Heart J 2001;22: 2015-24.
8. Sousa JE, Costa MA, Sousa AG, et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimuseluting stents in human coronary arteries. Circulation 2003;107:381-3.
9. Suzuki Y, Ikeno F, Koizumi T, et al. In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation. J Am Coll Cardiol Intv 2008;1:168 -73.
10. Gonzalo N, Serruys PW, García-García HM, et al. Quantitative ex vivo and in vivo comparison of lumen dimensions measured by optical coherence tomography and intravascular ultrasound in human coronary arteries. Rev Esp Cardiol 2009;62:615-24.
11. Takarada S, Imanishi T, Liu Y, et al. Advantage of next-generation frequency-domain optical coherence tomography compared with conventional time-domain system in the assessment of coronary lesion. Catheter Cardiovasc Interv 2010;75:202-6.
12. Tahara S, Bezerra HG, Baibars M, et al. In vitro validation of new Fourier-domain optical coherence tomography. EuroIntervention 2011;6:875-82.
13. Guagliumi G, Sirbu V. Optical coherence tomography: high resolution intravascular imaging to evaluate vascular healing after coronary stenting. Catheter Cardiovasc Interv 2008;72:237-47.
14. Bezerra H, Costa M, Guagliumi G, Rollins A, Simon D. Intracoronary optical coherence tomography: a comprehensive review: clinical and research applications. J Am Coll Cardiol Intv 2009;2:1035-46.
15. Guagliumi G, Musumeci G, Sirbu V, et al. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. J Am Coll Cardiol Intv 2010;3:531-9.
16. Bouma BE, Tearney GJ, Yabushita H, et al. Evaluation of intracoronary stenting by intravascular optical coherence tomography. Heart 2003;89:317-20.
17. Gonzalo N, Garcia-Garcia HM, Serruys PW, et al. Reproducibility of quantitative optical coherence tomography for stent analysis. EuroIntervention 2009;5:224 -32.
18. Okamura T, Onuma Y, García-García HM, et al. First-in-man evaluation of intravascular optical frequency-domain imaging (OFDI) of Terumo: a comparison with intravascular ultrasound and quantitative coronary angiography. EuroIntervention 2011;6:1037-45.
19. Marso S, Terstein P, Kereiakes D, Moses J, Lasala J, Grantham A. Percutaneous coronary intervention use in the United States: defining measures of appropriateness. J Am Coll Cardiol Intv 2012;5:229 -35.
20. Sonoda S, Morino Y, Ako J, et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the SIRIUS trial. J Am Coll Cardiol 2004;43:1959-63.
21. Cheneau E, Leborgne L, Mintz GS, et al. Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation 2003;108:43-7.
22. Kume T, Okura H, Kawamoto T, et al. Assessment of the coronary calcification by optical coherence tomography. EuroIntervention 2011; 6:768 -72.
23. Hassan A, Bergheanu S, Stijnen T, et al. Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. Eur Heart J 2012;31:1172-80.
24. Ozaki Y, Okumura M, Ismail TF, et al. The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomographybased natural history study. Eur Heart J 2010;31:1470-6.
25. Gutiérrez-Chico JL, Wykrzykowska J, Nüesch E, et al. Vascular tissue reaction to acute malapposition in human coronary arteries: sequential assessment with optical coherence tomography. Circ Cardiovasc Interv 2012;5:20 -9, S1-8.
26. Matsumoto D, Shite J, Shinke T, et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 2007;28:961-967.26.
27. Mehanna EA, Attizzani GF, Kyono H, Hake M, Bezerra HG. Assessment of coronary stent by optical coherence tomography, methodology and definitions. Int J Cardiovasc Imaging 2011;27:259-69.